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Eumycetoma is a mutilating, chronic, granulomatous, progressive disease of mainly the 
foot which is most commonly caused by Madurella mycetomatis. Treatment of this 
infection is difficult and success rates are poor, even although the fungus itself is 
extremely susceptible towards the azole class of antifungal agents, in vitro. These in 
vitro results were generated against fungal hyphae, but in vivo, mycetoma causative 
agents organize themselves in granules called grains. These grains are composed of the 
causative agent and a protective cement-material. Therefore, in developing a new 
therapy for mycetoma, the efficacy of the antimicrobial agents needs to be determined 
against grains. Until now, grains could only be generated in animal models. It is not 
possible to generate grains in vitro. Several animal models have been developed for 
mycetoma over the years. These models have been established in different hosts, 
ranging from mice and guinea pigs to goats and monkeys. But there is a large drawback 
to these animal models. From our own experience we noted that, already minutes after 
infection, mice become discomforted. They stay in this miserable state till 3 days after 
inoculation when they either tend to recover or die. The mortality rate for this infection 
model is relatively high (20-90% for the high load infections). Therefore there is a need 
for a model in which grains can be formed without having to use animals. At the 
moment, the most studied alternative for mammal infection models is the wax moth 
larvae Galleria mellonella. These larvae have a cellular and humoral immune system 
and can be maintained at 370C, conditions beneficial for mimicking the attacks 
mycetoma causative agents will encounter when entering the human host. Furthermore, 
these larvae have been used as alternative model systems to study the fungal infections 
candidiasis, aspergillosis and cryptococcosis. For some of these infections, therapeutic 
efficacy studies have been performed in these models, resembling the therapeutic 
response found in animal models and in the clinical situation, indicating that Galleria 
mellonella would indeed be a good model system for the fungal mycetoma infection. In 
this presentation, I will highlight the development of a M. mycetomatis grain model in 
larvae of the wax moth Galleria mellonella, the infection itself but also the responses 
towards commonly used antifungal agents will be shown. 
